Semi-Annual Statement Of Income

Cyfuse Biomedical K.K. - Filing #7345925

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Semi-annual statement of income
Statement of income
Net sales
61,112,000 JPY
374,477,000 JPY
Cost of sales
23,368,000 JPY
132,982,000 JPY
Ordinary profit (loss)
-586,187,000 JPY
-433,165,000 JPY
Gross profit (loss)
37,743,000 JPY
241,495,000 JPY
Selling, general and administrative expenses
735,180,000 JPY
666,585,000 JPY
Extraordinary losses
JPY
38,787,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
108,337,000 JPY
95,160,000 JPY
Depreciation
9,891,000 JPY
17,561,000 JPY
Operating profit (loss)
-697,437,000 JPY
-425,089,000 JPY
Profit (loss) before income taxes
-586,187,000 JPY
-471,953,000 JPY
Income taxes - current
3,024,000 JPY
2,009,000 JPY
Non-operating income
131,807,000 JPY
47,645,000 JPY
Non-operating income
Interest income
40,000 JPY
41,000 JPY
Income taxes
3,024,000 JPY
2,009,000 JPY
Non-operating expenses
20,556,000 JPY
55,721,000 JPY
Profit (loss)
-589,211,000 JPY
JPY
-589,211,000 JPY
JPY
-589,211,000 JPY
-589,211,000 JPY
JPY
JPY
-473,962,000 JPY
JPY
-473,962,000 JPY
-473,962,000 JPY
JPY
-473,962,000 JPY
JPY
JPY
Non-operating expenses
Interest expenses
9,774,000 JPY
7,457,000 JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.